Cargando…
Contemplations on MDMX (MDM4) driving triple negative breast cancer circulating tumor cells and metastasis
MDMX (MDM4) is emerging as an important breast cancer (BC) biomarker, and oncoprotein, that can be targeted in combination with its well-known family member MDM2. While MDM2 has previously been implicated in driving BC metastasis, information about the role of MDMX in driving circulating tumor cells...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals LLC
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707941/ https://www.ncbi.nlm.nih.gov/pubmed/31489110 http://dx.doi.org/10.18632/oncotarget.27134 |